ATLANTA,
August 5, 2021 (Newswire.com) –
Rezolut, LLC and CureMetrix, Inc.® have launched a pilot program within the Better New York Metropolis space with the goal of pairing superior expertise with operational excellence to enhance breast most cancers detection in ladies receiving routine screening mammograms. Rezolut, LLC is a nationwide, rising platform of diagnostic medical imaging providers, serving sufferers throughout the US with 23 outpatient imaging facilities and greater than 50 cell mammography items. Rezolut has a particular concentrate on ladies’s imaging and is quickly increasing its presence by natural progress and strategic partnerships in ladies’s healthcare.
“The CureMetrix partnership suits properly with Rezolut’s imaginative and prescient to offer top-notch affected person care partnered with revolutionary expertise — to attain higher well being outcomes,” stated Eddie Suttiratana, Vice President of Northeast Operations.
CureMetrix delivers Synthetic Intelligence (AI) options for screening mammography exams. The CureMetrix portfolio of scientific functions helps radiologists and healthcare professionals enhance scientific and operational outcomes whereas lowering complete price of offering screening providers. The top-to-end AI-based options from CureMetrix start with cmTriage® — a worklist optimization software that enables for the prioritization of suspicious exams. All exams are then processed by cmAssist® — an AI-based Laptop Aided Detection (CAD) algorithm that seamlessly identifies, marks, and quantifies suspicious lesions.
The anticipated outcomes of the pilot program are to point out that the partnership may end up in improved operational efficiencies throughout Rezolut’s mammography workflow whereas enhancing affected person outcomes by growing most cancers detection charges and lowering false positives.
Rezolut and CureMetrix have a historical past of working collectively on innovation. The 2 firms carried out a two-year trial of the cmAssist® CAD utility within the Los Angeles market with Rezolut’s Shin Imaging facilities.
Examine that trial right here: Rezolut-Shin Imaging-CureMetrix Case Examine
About Rezolut Medical Imaging, LLC
Rezolut is a high-growth medical imaging enterprise, dedicated to constructing an revolutionary, nationwide multi-modal platform by delivering high-quality service to our sufferers. To be taught extra about Rezolut, go to www.Rezolut.com.
About CureMetrix
CureMetrix is a worldwide chief in Synthetic Intelligence for medical imaging, dedicated to the development of expertise that improves illness detection and most cancers survival charges. Our mission is to assist save lives and assist improved outcomes. cmTriage is the primary FDA-cleared AI-based triage for mammography within the U.S. cmAssist is proprietary and investigational within the U.S. Go to www.CureMetrix.com.
Supply: Rezolut